After seeing a strong demand for initial public offering, Lifiencience Supriya will complete the basis of current shares notice.
The initial public offering of the active pharmaceutical material supplier (API) subscribes 71.5 times, with retail investor offers 56 times the portions provided for them. The non-institutional investor quota was booked 161 times, while the portion of quality institutional investors subscribed 31.8 times.
The IPO RS 700 Crore, which is open to subscribe for December 16-20, consists of fresh 200 crore RS problems and RS 500 Crore offers for sale. Acceptance of fresh problems will be used for working capital requirements and paying debts.
Here’s how to check the underlay status on the BSE website or IPO Registrar:
On the BSE website, follow these three steps:
1. Select the type of problem (equity), and the name of the problem (lificience supriya)
2. Enter the application number and number number
3. And finally the check box (I’m not a robot) and click the Search button
On the IPO Registrar website, follow these steps:
1. Choose a company name (supriya lifescience)
2. Select and hether entering the pan number, or application number, or ID DP / client, or account number / IFSC
3. And finally enter the captcha and click the send button
Incorporated in 2008, Lifesience Supriya has 38 APIs in October, focusing on segments such as antihistamines, analgesics, anesthesies, vitamins, anti-asthmatics and anti-allergies. This is the biggest exporter of Chlorpheniramine Maleate and Ketamine Hydrochloride produced 45-50% and 60-65%, from fire delivery from India between FY17 and FY21.
Lifesience Supriya shares traded with RS 130 premiums in the gray market, according to data from IPO Watch, 47 percent higher than the price of the problem RS 274 per share.
“At the top of the price ribbon, Supriya is available with a price / income ratio of 16.7 (annual FY22E) which seems reasonably priced compared to his colleagues,” said Geojit Financial Services.
Broker has set a “subscription” rating for the problem of short-term approaches considering strong financial performance, increasing margin, export exposure, capacity expansion and increased penetration in the regulated market.
Nirmal Bang, Marwadi Share, Angel One, Choice Broking and BP Wealth also have a subscription ranking on this problem.
The failed bidder will get a refund on December 24, and successful investors will get shares in their Demat account on December 27. Stocks tend to debut in BSE and national stock exchanges on December 28.